Cheung CYM, Halim NAA, Gan GG, Wang Y, et al. The APLC 2025 consensus recommendations on the assessment and management of
measurable residual disease in adults with acute lymphoblastic leukemia. Leuk Lymphoma 2026 Oct 30:1-19. doi: 10.1080/10428194.2026.2743349.
PMID: 42962083
|